.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Merck
Chinese Patent Office
Baxter
Cantor Fitzgerald
AstraZeneca
Deloitte
Colorcon
Cipla

Generated: November 21, 2017

DrugPatentWatch Database Preview

FORTOVASE Drug Profile

« Back to Dashboard

What is the patent landscape for Fortovase, and when can generic versions of Fortovase launch?

Fortovase is a drug marketed by Hoffmann La Roche and is included in one NDA. There is one patent protecting this drug.

This drug has forty patent family members in thirty-four countries and four supplementary protection certificates in three countries.

The generic ingredient in FORTOVASE is saquinavir. There is one drug master file entry for this compound. Additional details are available on the saquinavir profile page.

Summary for FORTOVASE

Medical Subject Heading (MeSH) Categories for FORTOVASE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann La Roche
FORTOVASE
saquinavir
CAPSULE;ORAL020828-001Nov 7, 1997DISCNYesNo► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: FORTOVASE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hoffmann La Roche
FORTOVASE
saquinavir
CAPSULE;ORAL020828-001Nov 7, 1997► Subscribe► Subscribe
Hoffmann La Roche
FORTOVASE
saquinavir
CAPSULE;ORAL020828-001Nov 7, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: FORTOVASE

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)0028942► Subscribe
Portugal1131037► Subscribe
China1326335► Subscribe
Argentina020013► Subscribe
South Korea100446118► Subscribe
Peru12402000► Subscribe
Russian Federation2219911► Subscribe
Japan3623166► Subscribe
CroatiaP20010341► Subscribe
Poland348350► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Tradename: FORTOVASE

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0048Belgium► SubscribePRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
70013Netherlands► SubscribePRODUCT NAME: SAQUINAVIR DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARD BAAR ZUURADDITIEZOUT, IN HET BIJZONDER HET MESYLAAT; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
/1996Austria► SubscribePRODUCT NAME: SAQUINAVIR UND SEINE SAEUREADDITIONSSALZE, INSBESONDERE SAQUINAVIRMESYLAT; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
C0044Belgium► SubscribePRODUCT NAME: SAQUINAVIR; REGISTRATION NO/DATE: EU/1/96/026/001 19961004
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Merck
Chinese Patent Office
Cipla
Novartis
QuintilesIMS
McKesson
Dow
Johnson and Johnson
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot